首页|Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal

Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Background:Hepatic ischemia-reperfusion injury(HIRI)stands as an unavoidable complication arising from liver surgery,profoundly intertwined with its prognosis.The role of lysine methyltransferase SET domain bifurcated 1(SETDB1)in HIRI remains elusive,despite its confirmation as a potential therapeutic target for diverse diseases.Here,we investigated the mechanism by which SETDB1 regulated HIRI.Methods:RNA sequencing data were used to identify the expression and potential targets of SETDB1 through bioinformatics analysis.To elucidate the impact of SETDB1 on HIRI,both an in vivo model of HIRI in mice and an in vitro model of hepatocyte hypoxia/reoxygenation were established.Biochemical and histological analyses were used to investigate the influence of SETDB1 on liver damage mediated by HIRI.Chromatin immunoprecipitation and coimmunoprecipitation were implemented to explore the in-depth mechanism of SETDB1 regulating HIRI.Results:We confirmed that hepatocellular SETDB1 was up-regulated during HIRI and had a close correlation with HIRI-related inflammation and apoptosis.Moreover,inhibition of SETDB1 could mitigate HIRI-induced liver damage,inflammation,and apoptosis.Through our comprehensive mechanistic investigation,we revealed that SETDB1 interacts with apoptosis-signal-regulating kinase 1(ASK1)and facilitates the methylation of its lysine residues.Inhibition of SETDB1 resulted in reduced phosphorylation of ASK1,leading to a marked suppression of downstream c-Jun N-terminal kinase(JNK)/p38 signaling pathway activation.The therapeutic effect on inflammation and apoptosis achieved through SETDB1 inhibition was nullified by the restoration of JNK/p38 signaling activation through ASK1 overexpression.Conclusions:The findings from our study indicate that SETDB1 mediates lysine methylation of ASK1 and modulates the activation of the ASK1-JNK/p38 pathway,thus involved in HIRI-induced inflammation and apoptosis.These results suggest that SETDB1 holds promise as a potential therapeutic target for mitigating HIRI.

Kang Xia、Tianyu Wane、Zhongbao Chen、Jiayu Guo、Bo Yu、Qi Chen、Tao Qiu、Jiangqiao Zhou、Shusen Zheng

展开 >

Department of Organ Transplantation,Renmin Hospital of Wuhan University,Wuhan,China

Department of Urology,Renmin Hospital of Wuhan University,Wuhan,China

Department of general surgery,Renmin Hospital of Wuhan University,Wuhan,China

Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,China

Key Laboratory of Combined Multi-Organ Transplantation,Ministry of Public Health,Hangzhou,China

Key Laboratory of Organ Transplantation,Hangzhou,Zhejiang Province,China

Key Laboratory of the Diagnosis and Treatment of Organ Transplantation,CAMS,Hangzhou,China

展开 >

2024

10.34133/research.0256

研究(英文)

研究(英文)

CSTPCD
ISSN：
年,卷(期)：2024.2024(3)